Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026)
Aytu Biopharma's (AYTU) quarterly Enterprise Value came in at -$26.7 million in Q1 2026, down 47.0% year-on-year from -$50.4 million in Q1 2025, and up 11.02% on a QoQ basis from -$30.0 million in Q4 2025.
Aytu Biopharma (AYTU) Enterprise Value (2011 - 2026) Analysis & Trends
Aytu Biopharma (AYTU) has 16 years of Enterprise Value data on file, last reported at -$26.7 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 47.0% year-over-year to -$26.7 million in Q1 2026; TTM through Mar 2026 was -$26.7 million, a 47.0% decrease from a year earlier, with the FY2025 full-year figure at -$31.0 million, down 54.71% from the prior year.
- Enterprise Value for Q1 2026 stood at -$26.7 million, up from -$30.0 million in the prior quarter.
- Over the last five years, Enterprise Value for AYTU reached as high as -$18.2 million in Q1 2025 and fell as low as -$32.6 million in Q3 2025.
- Historically, Enterprise Value has averaged -$23.0 million across 5 years, with a median of -$20.1 million in 2024.
- Across the five-year window, Enterprise Value soared 61.4% in 2022 and plunged 62.27% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$19.5 million in 2022, then dropped by 0.14% to -$19.5 million in 2023, then slipped by 4.45% to -$20.4 million in 2024, then sank by 47.2% to -$30.0 million in 2025, then gained by 11.02% to -$26.7 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$26.7 million in Q1 2026, -$30.0 million in Q4 2025, and -$32.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | Aytu Biopharma | 1.43 Mn | -25.28 Mn | 7.60 Mn | -26.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.72 Mn |
| Dec 31, 2025 | -30.03 Mn |
| Sep 30, 2025 | -32.63 Mn |
| Jun 30, 2025 | -30.95 Mn |
| Mar 31, 2025 | -18.17 Mn |
| Dec 31, 2024 | -20.40 Mn |
| Sep 30, 2024 | -20.11 Mn |
| Jun 30, 2024 | -20.01 Mn |
| Mar 31, 2024 | -19.76 Mn |
| Dec 31, 2023 | -19.53 Mn |
| Sep 30, 2023 | -19.96 Mn |
| Jun 30, 2023 | -22.99 Mn |
| Mar 31, 2023 | -19.18 Mn |
| Dec 31, 2022 | -19.50 Mn |
| Sep 30, 2022 | -23.81 Mn |
| Jun 30, 2022 | -19.36 Mn |
| Mar 31, 2022 | -27.61 Mn |
| Dec 31, 2021 | -35.28 Mn |
| Sep 30, 2021 | -40.56 Mn |
| Jun 30, 2021 | -50.15 Mn |